InvestorsHub Logo
icon url

Mooseface

10/16/20 7:06 PM

#27785 RE: Ecomike #27777

Connectyx Announces Grant of License from National Institutes of Health for Use of Novel Monoclonal Antibody to Treat Glioblastoma

I just copied and pasted the title of the article. It seems to speak for itself.. Why wouldn't they exercise their right (option) to commercialize this? That's the whole point of this pursuit.
icon url

trader59

10/16/20 7:46 PM

#27791 RE: Ecomike #27777

You're reading it correctly. This is a nothing-burger carefully worded for a stock sale. The PR was written to imply something big, but it isn't, it's an option to evaluate and consider commercialization of a drug that, obviously, nobody else wanted to push.
icon url

AllinFun

10/16/20 11:52 PM

#27818 RE: Ecomike #27777

Besides that you bought in March and then they execute exactly what they were reaching for since March and now all a sudden there is tons of questions lol hilarious.